- According to a study published in The Lancet,the number of patients requiring chemotherapy annually will rise to 15 million by 2040.
- The report has said that the incidence of cancer (excluding non-melanomatous skin cancers) is projected to rise from 17 million to 26 million between 2018 and 2040.The growth will be seen mostly in low and middle income countries.
- Further,between 2018 and 2040,the number of patients requiring first-course chemotherapy annually will increase from 9.8 million to 15 million.The most common indications for chemotherapy worldwide in 2040 will be lung cancer (16.4%), breast cancer (12.7%) and colorectal cancer (11.1%).
- This study was aimed at helping the global community scale up chemotherapy provisions.Strategic investments in chemotherapy service provision and cancer physicians are needed to meet the projected increased demand for chemotherapy in 2040.
- An Indian study “Projections of number of cancer cases in India by cancer groups’’ has noted that for the country the cancer cases are likely to go up from 9.5 lakh cases in 2010 to 11.5 lakh cases in 2020.
7 min read